These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 594055)

  • 21. [Delay in menstruation by the administration of 6-chloro-9 beta,10 alpha-pregna-1,4,6-triene-3,20-dione].
    Ferin J; Rombaut R
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):517-21. PubMed ID: 5510177
    [No Abstract]   [Full Text] [Related]  

  • 22. [Classification of oral contraceptives and its practical application to choice of prescriptions].
    Renaud M; Lecomte P; Soutoul JH
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1291-302. PubMed ID: 744869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
    Farkas M
    Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Examination of hormonal contraceptives by enzyme induction (author's transl)].
    Klinger G; Hempel E
    Zentralbl Gynakol; 1979; 101(5):302-5. PubMed ID: 463398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendations of the swiss family planning association regarding the indications for oral contraceptives (author's transl)].
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1330-2. PubMed ID: 530936
    [No Abstract]   [Full Text] [Related]  

  • 28. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives.
    Swanson SJ; Dengerink HA
    J Speech Hear Res; 1988 Dec; 31(4):569-74. PubMed ID: 3230886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications of oral contraceptive agents--a symposium. Action and efficacy of systemic contraceptive agents, and introduction of complications.
    Swerdloff RS
    West J Med; 1975 Jan; 122(1):20-6. PubMed ID: 1089002
    [No Abstract]   [Full Text] [Related]  

  • 31. [The low dosis gestagen therapy (author's transl)].
    Mall-Haefeli M; Ludwig KS; Spornitz UM; Uettwiller A
    Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):645-60. PubMed ID: 976705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum sialic acids in the normal menstrual cycle: a possible test for the prediction of ovulation.
    Naguib YA; Darwish NA; Nabil ; Shaarawy M; Nagui AR; Thabet S
    J Egypt Soc Obstet Gynecol; 1978 Jan; 4(1):37-48. PubMed ID: 12309831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical course and pathogenesis of oral contraceptive hypertension (author's transl)].
    Girndt J; Scheler F
    Med Klin; 1977 Oct; 72(41):1680-4. PubMed ID: 916953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral contraceptives: pharmacotherapy of normal women (author's transl)].
    Bühler FR
    Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A review of international clinical experience with a low-oestrogen oral contraceptive (author's transl)].
    Nadjafi C; Fontanilles F; Turri M
    Schweiz Rundsch Med Prax; 1976 Apr; 65(15):442-5. PubMed ID: 981163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of subcutaneous fat in predicting ovulation day.
    Jamaludin J; Nordin NM; Mohamad N; Etta KM
    Malays J Reprod Health; 1988 Jun; 6(1):65-9. PubMed ID: 12281593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of N-acetylneuraminic acid with long-time application of hormonal contraceptives (author's transl)].
    Klinger G; Kunstmann FW; Stelzner A
    Zentralbl Gynakol; 1981; 103(1):36-40. PubMed ID: 7053175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modification of cycle-dependent changes in the uterus by the intake of hormonal contraceptives].
    Bartl W; Nasr F; Bernaschek G
    Ultraschall Med; 1984 Apr; 5(2):74-6. PubMed ID: 6729435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)].
    Schmidt-Elmendorff HW
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):345-8. PubMed ID: 804642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.